J&K Reports 8 Covid-19 Deaths, 5394 New Cases| MENAFN.COM

Thursday, 19 May 2022 03:00 GMT

J&K Reports 8 Covid-19 Deaths, 5394 New Cases


(MENAFN- Kashmir Observer)



KO File Photo By Abid Bhat

Srinagar - Jammu and Kashmir reported eight covid-19 deaths, highest single-day toll of the present third wave, even as 5394 persons tested positive for the virus in the last 24 hours, officials said on Monday.

2045 of the fresh cases were reported from Jammu Division and 3349 from Kashmir, taking the overall tally to 402596, the officials said.

Regarding the deaths, they said, four each were reported from Jammu division and Kashmir Valley respectively. So far 4613 people have died due to the virus—2253 in Jammu division and 2360 in Kashmir Valley.

On Saturday last, the J&K recorded its highest daily case count of 6568 since the onset of the pandemic in 2020.

Giving district wise details, the officials said that Srinagar reported 963 cases, Baramulla 514, Budgam 574, Pulwama 188, Kupwara 267, Anantnag 229, Bandipora 252, Ganderbal 51, Kulgam 276, Shopian 35, Jammu 1204 , Udhampur 234, Rajouri 40, Doda 187, Kathua 34, Samba 71, Kishtwar 40, Poonch 15, Ramban 121 and Reasi 99.

Besides, they said, 3643 Covid-19 patients recovered during the time—1732 from Jammu Division and 1911 from Kashmir. So far 353374 people have recovered, leaving active case tally at 44609 —13542 in Jammu and 31067 in Kashmir.

They said there was no new confirmed case of mucormycosis (black fungus) reported today. So far 51 black fungus cases have been confirmed in J&K, the officials said.

They also informed that 33,147 ddoses of covid-19 vaccine were administered during the time in J&K.

MENAFN24012022000215011059ID1103585674


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.